Sangeeta Senapati, MD
Gynecology · Skokie, ILNPI 1164519930
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,406 of the $9,975 with a category attached, or 74.2%. 7 manufacturers reported payments, led by Myovant Sciences Inc. at 44.8% of the total.
Across 18 payments — averaging $554.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myovant Sciences Inc.$4K
- Pfizer$3K
- AbbVie$1K
- Covidien LP$440
- Coopersurgical, Inc.$97
- KARL Storz Endoscopy-america$22
- plus $13 from 1 others
What the payments were for
- Consulting fees$1,84418%
- Speaking & faculty fees$7,40674%
- Travel & lodging$1041%
- Food & beverage$6216%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myovant Sciences Inc. | 5 | $4,471 |
| Pfizer | 3 | $3,471 |
| AbbVie | 2 | $1,459 |
| Covidien LP | 5 | $440 |
| Coopersurgical, Inc. | 1 | $97 |
| KARL Storz Endoscopy-america | 1 | $22 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$5,649
How this compares
$9,975 in reported general payments places this provider in the 85th percentile of 68 gynecology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Norethindrone Acetate | 11 | $469 |
| Pregabalin | 11 | $134 |
| Misoprostol | 18 | $52 |
| Tizanidine Hcl | 13 | $50 |
| Triamcinolone Acetonide | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Skokie
- Frank TuSkokie$21K
- Anna BonadonnaSkokie$112
- Nicole WilliamsChicago$527K
- Nahla MerhiNew Lenox$492K
- Pierre JohnsonDecatur$360K
- Jack LenoxRockford$208K
- Lauren StreicherChicago$48K
- Monica MooreChicago$29K
- Catherine BrankinChicago$22K
- Obianuju Madueke-LaveauxChicago$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.